Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate Hydrofluoroalkane (BDP HFA) Nasal Aerosol in Subjects 12 Years of Age and Older With SAR
Conditions
Interventions
Beclomethasone dipropionate
Placebo Nasal Aerosol
Locations
4
United States
Teva Clinical Trial Site
Austin, Texas, United States
Teva Clinical Trial Site
New Braunfels, Texas, United States
Teva Clinical Trial Site
San Antonio, Texas, United States
Teva Clinical Trial Site
Waco, Texas, United States
Start Date
December 31, 2009
Primary Completion Date
February 28, 2010
Completion Date
February 28, 2010
Last Updated
December 3, 2021
NCT04815668
NCT06846385
NCT06837233
NCT06046391
NCT03570957
NCT05540717
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions